The Effect of ldoxuridine (IDU) on
Corneal Stromal Cells in Tissue Culture*
WALTER J. GEERAETS, GUY WONG, AND DUPONT GUERRY, Ill

Department of Ophthalmology, Medical College of Virginia, Richmond

An alarming increase in the severity
and frequency of the stromal forms of
herpetic keratitis has been reported
during the last decade (Thygeson and
Kimura, 1957; Thygeson, Kimura, and
Hogan, 1956; Kimura and Goodner,
1963; Bianchetti, 1963). This has led
to an intensive search for therapeutic
means for its management. The introduction in 1962 by Kaufman, Nesburn,
and Maloney of idoxuridine (IDU) as
an effective agent against herpes infection of the cornea has stimulated clinical and laboratory research to evaluate
its full therapeutic potential.
Initially, IDU was reported as favorably affecting the stromal forms of
herpetic keratitis. Kimura and Goodner (1963) and Maxwell (1963) found
this to be true in 50 to 85% of the
cases reported. Subsequently, Payrau
and Dohlman (1964) found that IDU
adversely affected the healing of stromal wounds as evidenced by tensile
strength determinations.
But other investigators (Polack and
Rose, 1964; Kaufman et al., 1964),
basing their results upon the decreased
tritiated thymidine uptake, reported
that IDU only moderately inhibited
the healing of stromal wounds. The
degree to which the decreased tritiated
thymidine uptake accurately reflected
a decreased mitosis has been questioned by Pelc (1963). The same author, as well as other investigators, has
expressed "reservations about assuming an invariable sequential relationship between DNA synthesis and mitotic division." Pelc found that in many
organs a fewer number of cells divided
than would be expected from the number of labeled cells found, thus indicating that DNA can be replaced in a
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cell nucleus without cell division taking
place.
Since the complete effect of IDU on
corneal cells is still not known, this investigation was conducted. During the
experimental phase of this study, a few
studies in vivo appeared in the literature (Kaufman et al., 1962; Maxwell,
1963; Kaufman et al., 1964; Ey,
Hughes, and Holmes, 1964), as well as
tissue culture work with various cells.
However, to our knowledge, no study
in vitro with corneal stromal cells has
been reported, although it has been
pointed out (Kaufman, personal communication) that the effect of IDU
may vary with the cell type used.
Materials and Methods

Cell Culture
Corneal tissue cultures were used.
Corneal explants were obtained from
chinchilla rabbit eyes and cultured under perforated cellophane in growth
medium (minimum essential medium),'
with L-glutamine (3 mg per ml), penicillin (100 µ, per ml), streptomycin (0.5
mg per ml), and 10% calf serum. The
pH was 7.4 which equilibrated with
5% C02 at 37 °C.
A cell strain of corneal stromal cells
which had undergone at least eight
passages was obtained and used in this
experiment (fig. 1).

ldoxuridine Medium
Growth medium containing idoxuridine was prepared by dissolving powdered IDU2 in the medium. First, a
1,000 µ,g per ml solution was prepared.
One-tenth dilutions ranging through
0.1 µ,g per ml were then prepared. This
material was filtered through Seitz fil' Grand Island Biological Company,
Grand Island, N.Y.
2 Nutritional
Biochemicals Corporation, Cleveland, Ohio.
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Fig. I-Corneal stromal cells in tissue culture (220 X).

ter pads before use. The medium was
kept in the dark at 4 °C and all had
been used 2 weeks from preparation .
At the end of the study, the medium
was cultured for aerobic and anaerobic
organisms and fungi and was found to
be sterile.

Cell Count
The cell cultures were washed twice
with 4-ml portions of salt solution of
the following composition: 8 gm of
NaCl, 4 gm of KC!, 1 gm of glucose
per 1,000 ml. To each plaque bottle
0.5 ml of 0.25 % trypsin-0.2 % Versene
solution was then added. This solution
was allowed to act for 8 minutes. The
bottles were shaken every 2 minutes
and examined microscopically to determine whether the cells were adequately
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matic chelating solution was achieved
by adding 1.5 ml of growth medium.
The cell suspension then was passed
through a number 25 gauge hypodermic needle. The cells were counted at
once in a hemocytometer. Six to ten
samples were counted from each bottle
to establish the average number of cells
with the more dilute cell suspensions.

Procedure
With the foregoing materials and
technics, IDU's effect on stromal tissue
culture cell growth was studied. In this
experiment, 72 plaque bottles (surface
area of 15 cm2 ) were plated with equal
aliquots of a cell suspension. Twentyfour hours later, when the cells had
been allowed to attach to the glass, a
cell count was determined in 18 bottles
selected at random. This value was
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considered to be the number of cells
attached to the glass at zero time
(29,700). The remaining 54 bottles
were divided randomly into six different groups. These cell cultures were
subjected to "!DU-media" of concentrations of 0, 0.1, 1, 10, 100, and 1,000
µ.g per ml. The media were changed
daily and cell counts were determined
at the end of 72, 120, and 168 hours
following exposure to IDU. The experiment was carried out in triplicate:
thus, three bottles from each group
were counted at the end of each of the
above periods. The total experiment
was repeated with a different strain of
stromal cells, leaving other variables
unchanged.

TABLE 1

Total Number of Cells in Each Bottle after Various Periods of Exposure to Different Concentrations of IOU

Exposure to
IDU for
hr

Results

The control bottles contained an average of 92,900 cells per bottle, while
the cell population treated with the
lowest concentration of IDU (0.1 µ.g
per ml) contained a mean of 51,900
cells per bottle (table 1 and fig. 2). This
difference proved to be statistically
significant at the 0.01 level.
The cell count of the cultures treated
with 1, 10, 100, and 1,000 µ.g of IDU
ml medium revealed 28,400, 25 ,000,
20,000, and 18,900 cells per bottle, respectively. These counts were of significant difference regarding the control group as well as the cells exposed
to 0.1 µ.g of IDU per ml of medium.
The level of significance was 0.05 or
better. The number of cells treated
with !DU-media, ranging from 1 to
1,000 µ.g per ml, revealed a decreasing
number of cells with increasing concentration of the IDU. However, these
slight differences were not significant
as these counts were below those of
time zero (29,700).

120 Hours
The cell count of the control bottles
revealed an average of 215,000 cells
per bottle; the bottles treated with 0.1,
1, 10, 100, and 1,000 µ.g of IDU per
ml had a mean of 102,000, 42,200,
33,800, 24,800, and 18,900 cells per
bottle, respectively. The number of
cells in the control group compared to
the treated groups was found to be sig32
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The observations made at the end of
the three different interaction periods
of IDU on cultured corneal stromal
cells (72, 120, 168 hours) are described
separately for each period.
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Fig. 2-Graph representing multiplication of corneal stromal cells in tissue culture
without (control) and with IDU present in the culture medium (0.1 to 1000 µg per ml).
nificant at the 0.01 level. There was
also a significant difference of the cell
number of those cultures exposed to
the weakest concentration of IDU (0.1
µ.g per ml), and those treated with
higher IDU concentrations (1, 10, 100,
and 1,000 µ.g of IDU per ml media) at
a level of 0.05 or better. Similar to the
72-hour observation, the cell number
decreased with the increase in IDU
concentration. The difference between
the cell counts in these experimental
groups was of no significance statistically.

168 Hours
The difference between the number
of cells in the control group compared
to those of the treated groups was even
more pronounced than for the time intervals of 72 and 120 hours of exposure to IDU. The control group showed
a 15-fold increase in cellular population (29,700 at time zero versus 462,000 at 168 hours). In contrast, the
weakest concentration of IDU in this
experiment permitted only a 3-fOld increase in the cellular population\~ur
ing tho "m' period (29,700 .i \ m'

zero versus 88,900 at 168 hours). This
3-fold increase in the number of cells
of the latter group again was significantly different from the populations
treated with the greater concentrations
of IDU. This was found at the 0.01
level.
As was noted in the group of shorter
exposure to IDU, there was only an
insignificant difference found between
the number of cells in the 1, 10, 100,
and 1,000 µg of IDU per ml of mediatreated populations, all which showed
cell counts similar to those at time
zero.
Throughout this experiment, there
was no significant difference in cell
counts within individual groups that
could have been attributed to the different periods of IDU exposure. Thus,
IDU interaction upon corneal stromal
cells for 72, 120, and 168 hours in
equal concentrations did not result in
significantly different cell counts.
When the total experiment was repeated with a different strain of stromal cells, the results obtained were
very similar to those above.
Discussion

The marked inhibition of cell population increase and its relation to the
concentration of IDU is consistent with
recent observations by others. The
growth inhibition of mouse leukemic
cells in culture by IDU was reported
by Mathias, Fischer, and Prusoff
(1959). These authors reported that
IDU, at ordinarily accepted therapeutic concentrations and less, permitted
only a single doubling of the population cells in culture, and thereafter
"cell death invariably commenced."
Ey, Hughes, and Holmes (1964)
found that, with concentrations of
IDU at less than therapeutic strength,
the multiplication of primary rabbit
kidney cells in culture was entirely
blocked. Cheong, Rich, and Eidenoff
(1960) have reported similar results
with cultures of human cervical carcinoma cells.
Studies in vivo by Polack and Rose
(1 964) with therapeutic doses of IDU
illustrated that there was a delay in cell
repopulation after stromal injury in
rabbits. Payrau and Dahlman (1964)
also found that stromal wound healing
was retf(rded in rabbits treated with
IDU. As was theorized by Polack,
"this inhibition should increase if IDU
ooul/ ' m>de mifable to fill the p<e-

mitotic cells." The more marked quantitative differences in cell counts, after
exposures to various concentrations of
IDU in this study in vitro, can be based
on this assumption of Polack.
The arrest of cellular multiplication
after exposure to a critical concentration of IDU may be explained by lysis
of the cells. Mathias and Fischer
(1959) found that murine leukemia
cells in 10- to 100-µg IDU solutions
underwent lysis even after doubling in
number.
The findings reported in this study
suggest that the proliferation of corneal stromal cells is inhibited by IDU.
These findings in vitro should be considered when IDU is clinically used in
cases where there is severe stromal involvement.
Summary

Corneal stromal cells were cultured
in vitro and exposed to various con-

centrations of idoxuridine (IDU), ranging from 0 to 1,000 µg of IDU per ml
of medium. Inhibition of cell multiplication occurred with concentrations
of 0.1 µg per ml. With concentrations
of 1.0 µg per ml and greater, there was
no increase in cell number from the
time of exposure to IDU.
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